Montreal (QUEBEC) – One of the important lessons that emerged from Dr. Mike Poole’s lecture, here, at the NÉOMED Institute last Friday, which he summarized in this interview, is the need for a better data collection in developing countries. Dr. Mike Poole, director, Global Health Office of the President, at the Bill and Melinda Gates […]
Montreal (QUEBEC) – Dr Terrence Kenakin, professor at the department of pharmacology at the University of North Carolina’s School of Medicine, explains how the concept of receptors has evolved over the last 10 years and the implications for drug discovery. It was the topic of a recent conference he gave at the NEOMED Institute. “For […]
Montreal (Canada) : This week, Thrasos Therapeutics, headquartered in the NÉOMED Institute, raised a $21 million series D financing lead by BDC Capital, a new investor, and SR One. Other current investors (Advanced Technology Ventures, Fonds de solidarité FTQ, Lumira Capital, MP Healthcare Venture Management, Pappas Ventures and SW Co) also participated in the operation. […]
Montreal (Quebec) – enGene, a Montreal-based biotechnology company, has just raised CAD $13.5 million in a Series B investment round led by Forbion Capital Partners, with participation of Lumira Capital and new investors Quebec’s Fonds de solidarité FTQ and Pharmstandard International. Inventor of a disruptive technology based on the idea of turning the gut into […]
Montréal (QUÉBEC) – Dr. Aled Edwards, founding CEO of the Structural Genomics Consortium (SGC) and professor at the University of Toronto, gives us a snapshot on his recent conference at the Neomed Institute where he spoke about the uncommon mission of the SGC. « In order to discover new aspects of medicine, we need to research on less well-studied […]